Samuel P. Malkin
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Projecting the Long-Term Cost-Effectiveness of Once-Weekly Insulin Icodec Versus Once-Daily Basal Insulin Analogs in Italy Using the Prime T2D Model.
Journal: Diabetes, obesity & metabolism
Published: May 27, 2026
Once-weekly semaglutide versus placebo for the treatment of type 2 diabetes and chronic kidney disease in Denmark: A long-term cost-effectiveness analysis based on FLOW.
Journal: Cardiovascular diabetology
Published: August 29, 2025
Cost-Effectiveness of Drug-Coated Balloons in the Treatment of Coronary Small Vessel Disease: A Report From the BASKET-SMALL 2 Randomized Controlled Trial.
Journal: Journal of the American Heart Association
Published: July 17, 2025
The Long-Term Cost-Effectiveness of Oral Semaglutide Versus Lower-Cost Liraglutide in the UK.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: November 11, 2024
The Impact of Unrelated Future Medical Costs on Economic Evaluation Outcomes for Different Models of Diabetes.
Journal: Applied health economics and health policy
Published: August 20, 2024
Early use of oral semaglutide in the UK: A cost-effectiveness analysis versus continuing metformin and SGLT-2 inhibitor therapy.
Journal: BMJ open
Published: September 29, 2023
Calibration of the IQVIA Core Diabetes Model to the stroke outcomes from the SUSTAIN 6 cardiovascular outcomes trial of once-weekly semaglutide.
Journal: Journal of medical economics
Published: August 01, 2023
The Short-Term Cost-Effectiveness of a Fixed-Ratio Combination of Insulin Degludec and Aspart: A Cost of Control Analysis in Australia and India.
Journal: Value in health regional issues
Published: July 05, 2023
Evaluating the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide 1 mg Versus Liraglutide 1.8 mg: A Health Economic Analysis in the UK.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: February 14, 2023
Evaluating the Clinical and Economic Outcomes Associated with Poor Glycemic Control in People with Type 1 Diabetes in the Netherlands.
Journal: ClinicoEconomics and outcomes research : CEOR
Published: October 11, 2022
Once-weekly semaglutide versus insulin aspart for the treatment of type 2 diabetes in the UK: A long-term cost-effectiveness analysis based on SUSTAIN 11.
Journal: Diabetes, obesity & metabolism
Published: July 27, 2022
Last Updated: 09/26/2026